Table of Content



1 Relevant Concepts of Pregabalin
1.1 Indications for Pregabalin
1.2 Development of Pregabalin in China
1.3 Governmental Approval of Pregabalin in China
1.4 The Impact of COVID-19 on Pregabalin sales in China


2 Sales of Pregabalin in China, 2016-2020
2.1 Sales Value of Pregabalin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Pregabalin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Pregabalin by Dosage Form in China, 2016-2020
2.3.1 Capsules
2.3.2 Analysis of Other Dosage Forms


3 Analysis of Major Pregabalin Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Pregabalin Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Pfizer Ltd
3.2.1 Enterprise Profile
3.2.2 Sales of LYRICA (Pfizer Ltd’s Pregabalin) in China
3.3 Chongqing Saiwei Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Laireike (Chongqing Saiwei Pharmaceutical Co., Ltd.’s Pregabalin) in China
3.4 Qilu Pharmaceutical (Hainan) Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Xisiping (Qilu Pharmaceutical (Hainan) Co., Ltd.’s Pregabalin) in China


4 Prices of Pregabalin for Different Manufacturers in China, 2020-2021
4.1 Pfizer Ltd (LYRICA)
4.2 Chongqing Saiwei Pharmaceutical Co., Ltd. (Laireike)
4.3 Qilu Pharmaceutical (Hainan) Co., Ltd. (Xisiping)


5 Prospect of Chinese Pregabalin drug Market, 2021-2025
5.1 Influential Factors of Chinese Pregabalin Market Development
5.1.1 The Impact of COVID-19 on Chinese Pregabalin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Pregabalin Capsules Registration in China
Chart Sales Value of Pregabalin Capsules over the World
Chart Sales Value of Pregabalin Capsules in China, 2016-2020
Chart Sales Value of Pregabalin Capsules in China by Region, 2016-2020
Chart Sales Volume of Pregabalin Capsules in China, 2016-2020
Chart Sales Volume of Pregabalin Capsules in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Pregabalin Manufacturers in China, 2016-2020
Chart Sales Value and Volume of LYRICA in China, 2016-2020
Chart Sales Value and Volume of Laireike in China, 2016-2020
Chart Sales Value and Volume of Xisiping in China, 2016-2020
Chart Referential Prices of LYRICA in China, 2020-2021
Chart Referential Prices of Laireike in China, 2020-2021
Chart Referential Prices of Xisiping in China, 2020-2021
Chart Forecast on Sales Value of Pregabalin in China, 2021-2025
Chart Forecast on Sales Volume of Pregabalin in China, 2021-2025



List of Tables

Table of Contents


1 Relevant Concepts of Pregabalin



  • 1.1 Indications for Pregabalin

  • 1.2 Development of Pregabalin in China     

  • 1.3 Governmental Approval of Pregabalin in China

  • 1.4 The Impact of COVID-19 on Pregabalin sales in China


 


2 Sales of Pregabalin in China, 2016-2020  



  • 2.1 Sales Value of Pregabalin

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Pregabalin    

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Pregabalin by Dosage Form in China, 2016-2020   

  • 2.3.1 Capsules

  • 2.3.2 Analysis of Other Dosage Forms


      


3 Analysis of Major Pregabalin Manufacturers in China in 2020



  • 3.1 Analysis of Market Share of Major Pregabalin Manufacturers     

  • 3.1.1 Investigation on Market Share by Sales Value    

  • 3.1.2 Investigation on Market Share by Sales volume 

  • 3.2 Pfizer Ltd

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of LYRICA (Pfizer Ltd’s Pregabalin) in China  

  • 3.3 Chongqing Saiwei Pharmaceutical Co., Ltd.  

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of Laireike (Chongqing Saiwei Pharmaceutical Co., Ltd.’s Pregabalin) in China

  • 3.4 Qilu Pharmaceutical (Hainan) Co., Ltd.

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Xisiping (Qilu Pharmaceutical (Hainan) Co., Ltd.’s Pregabalin) in China


 


4 Prices of Pregabalin for Different Manufacturers in China, 2020-2021



  • 4.1 Pfizer Ltd (LYRICA)

  • 4.2 Chongqing Saiwei Pharmaceutical Co., Ltd. (Laireike)

  • 4.3 Qilu Pharmaceutical (Hainan) Co., Ltd. (Xisiping)


 


5 Prospect of Chinese Pregabalin drug Market, 2021-2025



  • 5.1 Influential Factors of Chinese Pregabalin Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Pregabalin Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend


 


List of Charts



  • Chart Patent Information About Pregabalin Capsules Registration in China

  • Chart Sales Value of Pregabalin Capsules over the World   

  • Chart Sales Value of Pregabalin Capsules in China, 2016-2020  

  • Chart Sales Value of Pregabalin Capsules in China by Region, 2016-2020

  • Chart Sales Volume of Pregabalin Capsules in China, 2016-2020

  • Chart Sales Volume of Pregabalin Capsules in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Pregabalin Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of LYRICA in China, 2016-2020

  • Chart Sales Value and Volume of Laireike in China, 2016-2020 

  • Chart Sales Value and Volume of Xisiping in China, 2016-2020              

  • Chart Referential Prices of LYRICA in China, 2020-2021  

  • Chart Referential Prices of Laireike in China, 2020-2021          

  • Chart Referential Prices of Xisiping in China, 2020-2021    

  • Chart Forecast on Sales Value of Pregabalin in China, 2021-2025

  • Chart Forecast on Sales Volume of Pregabalin in China, 2021-2025